The results of our research suggest that EGFR, CCL2, PTGS2 and SERPINE1 proteins that play a significant role in the diabetic cardiomyopathy network may function as a druggable node to impact the repercussions of diabetes in cardiomyocytes. This evidence concerns the gene CCL2 and diabetic cardiomyopathy.